Explore evidence

0.6 %According to data from the Demographic and Health Surveys III 2016–2017, HIV seroprevalence in Burundi is 0.6% in men aged 15 to 49 years.

BurundiVIH/sidaobserved 2016–2017HAL · Unilimdocument of 62 observations

27.3 %As of 29 September 2024, children under five years of age constituted 27.3% of the total confirmed mpox cases in Burundi.

Burundimpoxobserved 29 September 2024Africa CDCdocument of 147 observations

6,250 contacts_tracedBurundi reported 6,250 cumulative mpox contacts traced, including 936 new contacts traced in week 39.

Burundimpoxobserved week 39Africa CDCdocument of 147 observations

The DRC, Uganda, Burundi, Kenya, and Rwanda serve as epicenters of ongoing mpox transmission.

Burundi · Kenya · Ouganda · RDC · RwandampoxAfrica CDCdocument of 110 observations

421 dischargesBurundi reported 421 cumulative mpox discharges, with 74 new discharges in week 39.

Burundimpoxobserved week 39Africa CDCdocument of 147 observations

3 countriesAs of the end of February 2025, three countries in the active phase — Burundi, Rwanda, and Central African Republic — were observing a declining trend in mpox transmission.

Burundi · Rwandampoxobserved end of February 2025Africa CDCdocument of 110 observations

50,000 test_kits50,000 test kits were delivered from Singapore to the Central African Republic, Burundi, and Uganda for Mpox diagnostics.

Burundi · OugandampoxAfrica CDCdocument of 72 observations

Burundi, CAR, Congo, DRC, Gabon, Kenya, Rwanda, and Uganda reported Clade I mpox cases.

Burundi · Gabon · Kenya · Ouganda · RDC · RwandaClade I · mpoxAfrica CDCdocument of 11 observations

16.4 %Burundi experienced a 16.4% increase in new suspected mpox cases in the past 6 weeks compared to the preceding 6 weeks.

BurundimpoxAfrica CDCdocument of 74 observations